Histological analysis showed reduced levels of phosphorylated PI3K and AKT, and decreased levels of MMP-2 in CX3CR1-KD groups than those in control groups, indicating downregulation of the aggressive propensity of tumor cells conferred by CX3CR1-KD treatments (Figure 7F). This evidence concerns the gene AKT1 and neoplasm.